Smithfield Trust’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.83M Buy
9,591
+159
+2% +$161K 0.38% 49
2025
Q4
$10.1M Buy
9,432
+301
+3% +$288K 0.45% 43
2025
Q3
$6.97M Sell
9,131
-3
-0% -$2.23K 0.31% 54
2025
Q2
$7.12M Hold
9,134
0.34% 51
2025
Q1
$7.54M Sell
9,134
-94
-1% -$78.2K 0.38% 47
2024
Q4
$7.13M Sell
9,228
-25
-0.3% -$20.7K 0.36% 48
2024
Q3
$8.2M Sell
9,253
-50
-0.5% -$45K 0.4% 45
2024
Q2
$8.43M Sell
9,303
-86
-0.9% -$68.8K 0.44% 44
2024
Q1
$7.31M Sell
9,389
-239
-2% -$170K 0.39% 47
2023
Q4
$5.61M Buy
9,628
+292
+3% +$170K 0.32% 52
2023
Q3
$5.02M Buy
9,336
+22
+0.2% +$11.3K 0.31% 51
2023
Q2
$4.37M Buy
9,314
+147
+2% +$61.6K 0.26% 54
2023
Q1
$3.15M Sell
9,167
-43
-0.5% -$14.5K 0.2% 71
2022
Q4
$3.37M Hold
9,210
0.23% 70
2022
Q3
$2.98M Sell
9,210
-242
-3% -$76.7K 0.21% 66
2022
Q2
$3.06M Buy
9,452
+75
+0.8% +$22.5K 0.22% 66
2022
Q1
$2.69M Buy
9,377
+1,078
+13% +$277K 0.17% 75
2021
Q4
$2.29M Hold
8,299
0.14% 86
2021
Q3
$1.91M Hold
8,299
0.13% 91
2021
Q2
$1.91M Buy
8,299
+12
+0.1% +$2.41K 0.13% 91
2021
Q1
$1.55M Sell
8,287
-166
-2% -$32.5K 0.11% 99
2020
Q4
$1.43M Sell
8,453
-857
-9% -$128K 0.1% 104
2020
Q3
$1.38M Buy
9,310
+152
+2% +$23.5K 0.11% 104
2020
Q2
$1.5M Buy
9,158
+306
+3% +$47K 0.14% 94
2020
Q1
$1.23M Buy
8,852
+919
+12% +$126K 0.13% 91
2019
Q4
$1.04M Sell
7,933
-80
-1% -$9.27K 0.1% 116
2019
Q3
$896K Buy
8,013
+336
+4% +$37.4K 0.09% 116
2019
Q2
$850K Buy
7,677
+400
+5% +$47.1K 0.09% 116
2019
Q1
$944K Buy
7,277
+114
+2% +$13.9K 0.1% 109
2018
Q4
$829K Buy
7,163
+3,916
+121% +$437K 0.1% 105
2018
Q3
$348K Hold
3,247
0.04% 197
2018
Q2
$277K Buy
3,247
+1,627
+100% +$134K 0.03% 219
2018
Q1
$125K Sell
1,620
-820
-34% -$66K 0.02% 357
2017
Q4
$206K Buy
2,440
+885
+57% +$75.3K 0.03% 278
2017
Q3
$133K Hold
1,555
0.02% 349
2017
Q2
$128K Hold
1,555
0.02% 368
2017
Q1
$131K Hold
1,555
0.02% 358
2016
Q4
$114K Hold
1,555
0.02% 379
2016
Q3
$125K Hold
1,555
0.02% 355
2016
Q2
$122K Sell
1,555
-1
-0.1% -$75 0.02% 352
2016
Q1
$112K Buy
1,556
+1,256
+419% +$95K 0.02% 363
2015
Q4
$25K Buy
+300
New +$24.9K 0.01% 578
2014
Q1
Sell
-120
Closed -$6K 846
2013
Q4
$6K Buy
+120
New +$6.01K ﹤0.01% 747

Other funds holding LLY

Smithfield Trust's LLY Position: Q1 2026 in Review

Smithfield Trust increased its Eli Lilly (LLY) stake by 1.7% in Q1 2026, buying an estimated $161K and bringing the position to 9,591 shares worth $8.83M. The position accounts for 0.38% of the portfolio, ranked #49.

Smithfield Trust first reported a position in LLY in Q4 2013 and has held it in 43 quarters since. The position peaked at $10.1M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Smithfield Trust held 9,591 shares of Eli Lilly worth $8.83M as of Q1 2026.
  • Smithfield Trust bought 159 Eli Lilly shares in Q1 2026, an estimated $161K.
  • Eli Lilly made up 0.38% of Smithfield Trust's portfolio in Q1 2026, its #49 holding.
  • Smithfield Trust first reported a position in Eli Lilly in Q4 2013 and has held it in 43 quarters since.
  • Smithfield Trust's Eli Lilly position peaked at $10.1M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Smithfield Trust's 13F filing for Q1 2026, filed 8 May 2026.